 - link Copy Url
- [  Share on twitter ](https://twitter.com/intent/tweet?text=Viatris Receives its First BSI Certification for Minimized Risk of AMR https://www.3blmedia.com/markdownify/node/1250186?absolute=1&via=3blnews "link to 3 B L Media's Twitter")
- [  Share on linkedin ](https://www.linkedin.com/shareArticle?mini=true&url=https://www.3blmedia.com/markdownify/node/1250186?absolute=1 "link to 3 B L Media's Linkedin")
- [  Share on facebook ](https://www.facebook.com/sharer/sharer.php?u=https://www.3blmedia.com/markdownify/node/1250186?absolute=1 "link to 3 B L Media's Facebook")
- [ email Share via email ](mailto:?subject=Viatris Receives its First BSI Certification for Minimized Risk of AMR&body=ESG News from Viatris https://www.3blmedia.com/markdownify/node/1250186?absolute=1 "Share via email")
 
 

 [Health &amp; Healthcare](/CSR-News/health-healthcare)

 # Viatris Receives its First BSI Certification for Minimized Risk of AMR

 


 

 Feb 20, 2024 10:00 AM ET

  ![hands in purple gloves handling a blue-speckled petri dish](/sites/default/files/styles/carousel_2x/public/images/amr_viatris_022024kh1.png) 

In January 2024, Viatris was notified that its Aurangabad, India, facility has received certification from the British Standards Institution (BSI) for meeting a new industry standard on Minimized Risk of Antimicrobial Resistance (AMR).

The standard was facilitated by BSI for the AMR Industry Alliance, an organization made up of over 100 companies and associations from across the life-sciences industry with the shared goal of providing sustainable solutions to curb AMR. The certification is designed to encourage drug manufacturers and those in the supply chain to prioritize the sustainable production of antibiotics.

“We are proud to be the first pharmaceutical site in India to achieve this important Minimized Risk of Antimicrobial Resistance certification from BSI, demonstrating our commitment to controlling antibiotic discharge,” said Sanjeev Sethi, Chief Operations Officer, Viatris. “Many thanks to our cross-functional team members for continuing to implement sustainable systems and processes that advance the responsible manufacturing of antibiotics.”

“Viatris having gained independent certification, and the first to do so in India, is a reflection of their leadership and commitment to tackling global AMR,” said Steve Brooks, Advisor and Manufacturing Work Group Lead, AMR Industry Alliance. “From their initial days with the Alliance, Viatris has been a key contributor to achieving greater results in our shared goal of providing sustainable solutions to curb AMR while being responsible stewards of the environment.”

AMR is recognized around the world as a significant threat to global health and economic development and is a major driver of death globally. Recent research shows that in 2019, more than 1.2 million people are estimated to have died directly from antibiotic-resistant bacterial infections. By 2050, it is estimated that AMR will cause more deaths than cancer unless concerted efforts are undertaken to counter its progression.1

**Viatris’ Commitment to Combatting AMR**

Viatris remains committed to doing its part to address AMR by advancing access, stewardship and responsible manufacturing. Access to a wide array of high-quality antimicrobials and timely treatment are key in mitigating the rise of AMR. The company currently has approximately 90 antimicrobials in its global portfolio, including antibiotics that can be valuable in treating resistant bacteria. As a founding member of the AMR Industry Alliance (AMRIA), Viatris is committed to partnering across the industry to collectively advance initiatives addressing AMR.

1 The Review on Antimicrobial Resistance – White Paper, 2014



 

 

 

 

 

 

 

 [![Viatris logo](/sites/default/files/2023-01/Viatris%20Logo_1.jpeg)](/profiles/viatris)

 



 

### More from Viatris

###### [Collaborating to Address Antimicrobial Resistance ](/news/collaborating-address-antimicrobial-resistance)

 Nov 18, 2025 10:00 AM ET

  



###### [Policy Engagement to Break Down Barriers to Access and Build Resilient Health Systems at Viatris](/news/policy-engagement-break-down-barriers-access-and-build-resilient-health-systems-viatris)

 Nov 4, 2025 10:00 AM ET

  



###### [Collaborating to Address Antimicrobial Resistance at Viatris](/news/collaborating-address-antimicrobial-resistance-viatris)

 Oct 28, 2025 9:15 AM ET

  



###### [How Viatris is Fighting Infectious Disease](/news/how-viatris-fighting-infectious-disease)

 Oct 21, 2025 9:15 AM ET

  



###### [How Viatris Prevents and Manages NCDs](/news/how-viatris-prevents-and-manages-ncds)

 Oct 15, 2025 9:25 AM ET

  



###### [World Mental Health Day 2025: Empowering Minds, Breaking Barriers](/news/world-mental-health-day-2025-empowering-minds-breaking-barriers)

 Oct 10, 2025 9:00 AM ET

  



###### [Viatris’ Work To Advance Access and Public Health](/news/viatris-work-advance-access-and-public-health)

 Oct 7, 2025 9:45 AM ET

  



###### [The Importance of a Global, Resilient Supply Chain to Access](/news/importance-global-resilient-supply-chain-access)

 Sep 30, 2025 10:45 AM ET